Exclusive

Publication

Byline

Eisai launches anti cancer agent Halaven in China

Singapore, Jan. 17 -- Japan headquartered Eisai Co., Ltd. has announced that it has launched the in-house developed anticancer agent Halaven(R) (generic name: eribulin mesylate) in China. Halaven is ... Read More


International research collaboration reveals treatment of blood cancers

Singapore, Jan. 17 -- International research collaboration between the United States and Australia has revealed a promising new drug that could treat high-risk leukemia. US based OncoTartis, Inc. and... Read More


Thailand rapidly screens out pneumonia cases from China

Singapore, Jan. 17 -- Health surveillance systems have been rapidly deployed at four of Thailand's most important international airports to screen out any visitors afflicted by pneumonia in the wake o... Read More


InterVenn Biosciences advances glycoproteomics for complex disease therapies

Singapore, Jan. 17 -- US based InterVenn Biosciences has announced multiple achievements in its development of AI-enabled glycoproteomics, as it looks to solving difficult challenges in various diseas... Read More


AVROBIO announces clinical and regulatory progress for Gaucher Disease Program

Singapore, Jan. 17 -- US based AVROBIO, a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, has received notice of clearance from the U.S. F... Read More


ASKA, KinoPharma unite to treat cervical dysplasia

Singapore, Jan. 16 -- ASKA Pharmaceutical Co., Ltd. and KinoPharma, Inc., both based in Tokyo, announced that they have entered into an option agreement for an exclusive license for the development an... Read More


Novartis Malaysia snags Top Employer Award for 2020

Singapore, Jan. 16 -- Novartis Malaysia, a global leader in the healthcare space has been awarded the Top Employer for 2020. A highly sought after recognition, this certificate was given by the indepe... Read More


WuXi Biologics and Bayer enter into acquisition agreement

Singapore, Jan. 16 -- WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Bayer... Read More


A2A, Daewoong to co-develop novel oncology treatments

Singapore, Jan. 16 -- A2A Pharmaceuticals Inc. (A2A) announced an agreement to design and co-develop oncology drug candidates with Daewoong Pharmaceutical Co., Ltd. (Daewoong), a major pharmaceutical ... Read More


Researchers to produce 3D comprehensive map of human brain

Singapore, Jan. 16 -- Scientists from the National University of Singapore (NUS) are working as members of an international team to produce a first-of-its-kind ultra-high resolution 3D comprehensive m... Read More